申请人:H. Lundbeck A/S
公开号:US06514993B1
公开(公告)日:2003-02-04
The present invention relates to a novel series of 4-phenylpiperazines, 4-phenylpiperidines and 4-phenyl-1,2,3,6-tetrahydropyridines compounds of general formula (I)
wherein A is alkylene, alkenylene, alkynylene, and C3-7 cycloalkylene; R1 is a C3-10 alkyl, alkenyl, or alkynyl group, cycloalk(en)yl, cycloalk(en)yl-alk(en/yn)yl, trifluoromethylsulfonyl, or alkylsulfonyl, R2-R5 are optional substituents; R9 and R10 are hydrogen, alkyl or together form an ethylene or propylene bridge; W is O or S; V is O, S, CR6R7, or NR8 wherein R6, R7, and R8 are hydrogen or alkyl, alkenyl, cycloalkyl, cycloalkylalkyl, optionally substituted arylalkyl or aryl, or R6 and R7 constitute a 3-7 membered spiro ring; Z is —(CH2)m—, m being 2 or 3 or Z is —CH═CH—; X is N, C or CH; show effects on central serotonin 5-HT1A and dopamine D2 receptors. Thus the novel compounds are useful in the treatment of certain psychic and neurologic disorders, in particular psychosis.
本发明涉及一种新型系列的4-苯基哌嗪、4-苯基哌啶和4-苯基-1,2,3,6-四氢吡啶化合物,其通式为(I),其中A为烷基、烯基、炔基和C3-7环烷基;R1为C3-10烷基、烯基或炔基、环烷(烯)基、环烷(烯)基-烷(炔)基、三氟甲基磺酰基或烷基磺酰基,R2-R5为可选取代基;R9和R10为氢、烷基或一起形成乙烯或丙烯桥;W为O或S;V为O、S、CR6R7或NR8,其中R6、R7和R8为氢或烷基、烯基、环烷基、环烷基烷基、可选取代芳基烷基或芳基,或R6和R7构成3-7成员螺环;Z为—(CH2)m—,m为2或3,或Z为—CH═CH—;X为N、C或CH;对中枢5-羟色胺1A受体和多巴胺D2受体具有影响。因此,这些新型化合物在治疗某些精神和神经疾病,特别是精神病方面具有用途。